Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Mind
Political anger affects the body differently to other forms of anger
51¶¯Âþ
Health
Australia is battling its largest diphtheria outbreak in living memory
51¶¯Âþ
Health
How ageing on Earth mimics the effects of space travel
Comment
Mathematics
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
51¶¯Âþ
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Epic dreaming is leaving people exhausted and distressed
3
Photos reveal unexpected details from the world's first atomic test
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
6
How I used psychology to come back from the worst year of my life
7
Women’s better memories may delay Alzheimer’s diagnosis by years
8
The ‘doomsday’ glacier’s giant ice shelf is about to break away
9
Australia is battling its largest diphtheria outbreak in living memory
10
Putting CO2 into rocks and getting hydrogen out is climate double win
